T Cell Response to SARS-CoV-2 Coinfection and Comorbidities is a research paper published in Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: R01CA221867
National Cancer Institute
Grant: R01AI121180
National Cancer Institute
Grant: R21AI167793
National Cancer Institute
Grant: LC210150
NIH HHS
Grant: R01CA221867,R01AI121180 and R21AI167793
National Institutes of Health
Grant: 1R21AI167793-01A1
Combating chronic neuroinflammatory disorders by targeting NAC1
National Institutes of Health
Grant: 5R01CA221867-03
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
National Institutes of Health
Grant: 5R01AI121180-04
Stem cell-derived regulatory T cells for therapeutic use in arthritis
FWCI
1.36
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals